NAD/Carnation
This article was originally published in The Tan Sheet
Executive Summary
Nestle's failure to discontinue ad claims stating Carnation Good Start infant formula is easier to digest, more similar to breast milk than other formulas warrants FTC referral, National Advertising Division of the Council of Better Business Bureaus says in recently released Case Report. NAD deemed claims unsubstantiated in response to Similac marketer Abbott Lab's challenge last year (1"The Tan Sheet" Feb. 12, 2001, p. 20). In separate case involving a J&J/Merck challenge for Novartis' claims that Maalox Quick Dissolve neutralizes more acid and dissolves faster than Pepcid Complete, NAD says it has closed the case since Novartis discontinued disputed ads permanently...
You may also be interested in...
Nestle Carnation Good Start Infant Formula "Comfort Proteins" Unique - NAD
The hydrolyzed whey "Comfort Proteins" in Nestle's Carnation Good Start infant formulas are unique to the product and do not mislead consumers, the National Advertising Division of the Council of Better Business Bureaus rules in its November NAD Case Reports.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.